Stay updated with breaking news from Nasdaq Rvnc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month […]
Innovis Asset Management LLC lifted its stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 266.1% in the third quarter, HoldingsChannel reports. The firm owned 38,501 shares of the biopharmaceutical company’s stock after purchasing an additional 27,984 shares during the period. Innovis Asset Management LLC’s holdings in Revance Therapeutics were worth $442,000 at the […]
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) shares shot up 12.5% during mid-day trading on Tuesday . The company traded as high as $5.81 and last traded at $5.74. 615,845 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 1,640,345 shares. The stock had previously closed at […]
Rice Hall James & Associates LLC lifted its position in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 23.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 683,937 shares of the biopharmaceutical company’s stock after buying an additional […]
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 14,390,000 shares, a growth of 16.0% from the December 15th total of 12,400,000 shares. Based on an average trading volume of 1,720,000 shares, the short-interest ratio […]